www.alldocs.info « cancers »
by www.alldocs.info
the most recent document references on :: cancers
Google
 
 Web   cancers.alldocs.info 
 
    Languages: malattie oncologiche  cancers  cancer  cancer  Krebse          Found 1779 documents         Page 10 of 60   Pages:  <<  <  5  6  7  8  9  10  11  12  13  14  15  >  >> 
 
 
 
   cancers cancers
     colon cancer colon cancer
  cancers.alldocs.infohomepage
www.alldocs.infowww.alldocs.info


 

  Legenda: last week last month

  [271] Population-based fecal occult blood screening for colon cancer ...
      PDF [200,4 KB]  From [www.cmaj.ca]  Last viewed: 07.09.2006
for colorectal cancer screening by the recognized scientific bodies, and is not paid for by Medicare or private insurers. Any patients who anticipate trying this technique would probably want to assure that the newer 3-D imaging using multi-slice scanning is used, rather than the more readily available but less reliable 2-D equipment. • The risks related to radiation with CT colonography remain uncertain. Fecal DNA Testing: This test involves collection of a stool sample at home that is mailed to a central laboratory. The laboratory checks for abnormal DNA shed from the surface of colon cancers and polyps. • The test detects 52% of colon cancers and 15% of large polyps. If negative it is repeated every 3 to 5 years. This test is better than a stool blood test but much more expensive. Fecal DNA testing is not nearly as effective as ...

  [272] G protein-coupled lysophosphatidic acid receptors stimulate ...
      PDF   From [stke.sciencemag.org]  Last viewed: 07.09.2006
for colorectal cancer screening by the recognized scientific bodies, and is not paid for by Medicare or private insurers. Any patients who anticipate trying this technique would probably want to assure that the newer 3-D imaging using multi-slice scanning is used, rather than the more readily available but less reliable 2-D equipment. • The risks related to radiation with CT colonography remain uncertain. Fecal DNA Testing: This test involves collection of a stool sample at home that is mailed to a central laboratory. The laboratory checks for abnormal DNA shed from the surface of colon cancers and polyps. • The test detects 52% of colon cancers and 15% of large polyps. If negative it is repeated every 3 to 5 years. This test is better than a stool blood test but much more expensive. Fecal DNA testing is not nearly as effective as ...

  [273] Vascular Endothelial Growth Factor in Human Colon Cancer: Biology ...
      PDF [576,3 KB]  From [theoncologist.alphamedpress.org]  Last viewed: 07.09.2006
for colorectal cancer screening by the recognized scientific bodies, and is not paid for by Medicare or private insurers. Any patients who anticipate trying this technique would probably want to assure that the newer 3-D imaging using multi-slice scanning is used, rather than the more readily available but less reliable 2-D equipment. • The risks related to radiation with CT colonography remain uncertain. Fecal DNA Testing: This test involves collection of a stool sample at home that is mailed to a central laboratory. The laboratory checks for abnormal DNA shed from the surface of colon cancers and polyps. • The test detects 52% of colon cancers and 15% of large polyps. If negative it is repeated every 3 to 5 years. This test is better than a stool blood test but much more expensive. Fecal DNA testing is not nearly as effective as ...

  [274] Nonproteic Antioxidant Status in Plasma of Subjects with Colon Cancer
      PDF [145,9 KB]  From [www.ebmonline.org]  Last viewed: 07.09.2006
for colorectal cancer screening by the recognized scientific bodies, and is not paid for by Medicare or private insurers. Any patients who anticipate trying this technique would probably want to assure that the newer 3-D imaging using multi-slice scanning is used, rather than the more readily available but less reliable 2-D equipment. • The risks related to radiation with CT colonography remain uncertain. Fecal DNA Testing: This test involves collection of a stool sample at home that is mailed to a central laboratory. The laboratory checks for abnormal DNA shed from the surface of colon cancers and polyps. • The test detects 52% of colon cancers and 15% of large polyps. If negative it is repeated every 3 to 5 years. This test is better than a stool blood test but much more expensive. Fecal DNA testing is not nearly as effective as ...

  [275] Assignment of the serologically defined colon cancer antigen 1 ...
      PDF [7,9 KB]  From [content.karger.com]  Last viewed: 07.09.2006
45 Retinol inhibits the growth of Retinoic Acid-resistant colon cancer cells Presenter Jessica Leland Collaborators Professor Michelle Lane, Alice Dillard, and Erik Wilder, Department of Human Ecology Department Nutrition Abstract Retinoids, derivatives of Vitamin A, are responsible for inducing differentiation and inhibiting cell growth in colon cancer . Retinoic Acid (RA) is unable to inhibit the growth of cells that become RA-resistant through alteration in metabolism or the loss of retinoic acid or retinoic “X” receptor activity. We investigated the ability of the more physiologically relevant retinoid, retinol, to inhibit the growth of RA-resistant colon cancer cell lines, determined the bioactive metabolites produced within these cells, and the mechanism by which growth is inhibited. HCT-116, SW620, and WiDr cells were treated with 0 (control), ...

  [276] The Src-Induced Mesenchymal State in Late-Stage Colon Cancer Cells
      PDF [7,9 KB]  From [content.karger.com]  Last viewed: 07.09.2006
45 Retinol inhibits the growth of Retinoic Acid-resistant colon cancer cells Presenter Jessica Leland Collaborators Professor Michelle Lane, Alice Dillard, and Erik Wilder, Department of Human Ecology Department Nutrition Abstract Retinoids, derivatives of Vitamin A, are responsible for inducing differentiation and inhibiting cell growth in colon cancer . Retinoic Acid (RA) is unable to inhibit the growth of cells that become RA-resistant through alteration in metabolism or the loss of retinoic acid or retinoic “X” receptor activity. We investigated the ability of the more physiologically relevant retinoid, retinol, to inhibit the growth of RA-resistant colon cancer cell lines, determined the bioactive metabolites produced within these cells, and the mechanism by which growth is inhibited. HCT-116, SW620, and WiDr cells were treated with 0 (control), ...

  [277] Polymyositis Successfully Treated with Surgical Resection of Colon ...
      PDF [7,9 KB]  From [content.karger.com]  Last viewed: 07.09.2006
45 Retinol inhibits the growth of Retinoic Acid-resistant colon cancer cells Presenter Jessica Leland Collaborators Professor Michelle Lane, Alice Dillard, and Erik Wilder, Department of Human Ecology Department Nutrition Abstract Retinoids, derivatives of Vitamin A, are responsible for inducing differentiation and inhibiting cell growth in colon cancer . Retinoic Acid (RA) is unable to inhibit the growth of cells that become RA-resistant through alteration in metabolism or the loss of retinoic acid or retinoic “X” receptor activity. We investigated the ability of the more physiologically relevant retinoid, retinol, to inhibit the growth of RA-resistant colon cancer cell lines, determined the bioactive metabolites produced within these cells, and the mechanism by which growth is inhibited. HCT-116, SW620, and WiDr cells were treated with 0 (control), ...

  [278] Adjuvant Therapy with Edrecolomab versus Observation in Stage II ...
      PDF [7,9 KB]  From [content.karger.com]  Last viewed: 07.09.2006
45 Retinol inhibits the growth of Retinoic Acid-resistant colon cancer cells Presenter Jessica Leland Collaborators Professor Michelle Lane, Alice Dillard, and Erik Wilder, Department of Human Ecology Department Nutrition Abstract Retinoids, derivatives of Vitamin A, are responsible for inducing differentiation and inhibiting cell growth in colon cancer . Retinoic Acid (RA) is unable to inhibit the growth of cells that become RA-resistant through alteration in metabolism or the loss of retinoic acid or retinoic “X” receptor activity. We investigated the ability of the more physiologically relevant retinoid, retinol, to inhibit the growth of RA-resistant colon cancer cell lines, determined the bioactive metabolites produced within these cells, and the mechanism by which growth is inhibited. HCT-116, SW620, and WiDr cells were treated with 0 (control), ...

  [279] Circulating Insulin-like Growth Factor-I Levels Regulate Colon ...
      PDF [467,0 KB]  From [cancerres.aacrjournals.org]  Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that connects the small intestine to the rectum. Cancer can begin in any part of the colon , but before cancer develops, changes usually occur in the organ’s lining. One change is a tissue growth called a polyp, which is a benign growth that can become malignant (cancerous) over time. Once detected, a polyp may be removed, preventing it from becoming cancerous. Who is at risk? • People over 50 • People with a personal history of colon or rectal cancer or chronic inflammatory bowel disease • People with a strong family history of colon or rectal cancer or polyps, or any type of cancer • People who are physically inactive • People who eat high-fat, low-fiber diets • Tobacco users What are the symptoms? • A change in bowel habits lasting for more ...

  [280] Four New Colon Cancer Susceptibility Loci, Scc6 to Scc9 in the Mouse
      PDF [111,8 KB]  From [cancerres.aacrjournals.org]  Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that connects the small intestine to the rectum. Cancer can begin in any part of the colon , but before cancer develops, changes usually occur in the organ’s lining. One change is a tissue growth called a polyp, which is a benign growth that can become malignant (cancerous) over time. Once detected, a polyp may be removed, preventing it from becoming cancerous. Who is at risk? • People over 50 • People with a personal history of colon or rectal cancer or chronic inflammatory bowel disease • People with a strong family history of colon or rectal cancer or polyps, or any type of cancer • People who are physically inactive • People who eat high-fat, low-fiber diets • Tobacco users What are the symptoms? • A change in bowel habits lasting for more ...

  [281] Growth Inhibition of Human Colon Cancer Cells by Nitric Oxide (NO ...
      PDF [181,9 KB]  From [cancerres.aacrjournals.org]  Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that connects the small intestine to the rectum. Cancer can begin in any part of the colon , but before cancer develops, changes usually occur in the organ’s lining. One change is a tissue growth called a polyp, which is a benign growth that can become malignant (cancerous) over time. Once detected, a polyp may be removed, preventing it from becoming cancerous. Who is at risk? • People over 50 • People with a personal history of colon or rectal cancer or chronic inflammatory bowel disease • People with a strong family history of colon or rectal cancer or polyps, or any type of cancer • People who are physically inactive • People who eat high-fat, low-fiber diets • Tobacco users What are the symptoms? • A change in bowel habits lasting for more ...

  [282] Counterpoint: From Animal Models to Prevention of Colon Cancer ...
      PDF [32,8 KB]  From [cebp.aacrjournals.org]  Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that connects the small intestine to the rectum. Cancer can begin in any part of the colon , but before cancer develops, changes usually occur in the organ’s lining. One change is a tissue growth called a polyp, which is a benign growth that can become malignant (cancerous) over time. Once detected, a polyp may be removed, preventing it from becoming cancerous. Who is at risk? • People over 50 • People with a personal history of colon or rectal cancer or chronic inflammatory bowel disease • People with a strong family history of colon or rectal cancer or polyps, or any type of cancer • People who are physically inactive • People who eat high-fat, low-fiber diets • Tobacco users What are the symptoms? • A change in bowel habits lasting for more ...

  [283] Underreporting of Family History of Colon Cancer: Correlates and ...
      PDF [32,9 KB]  From [cebp.aacrjournals.org]  Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that connects the small intestine to the rectum. Cancer can begin in any part of the colon , but before cancer develops, changes usually occur in the organ’s lining. One change is a tissue growth called a polyp, which is a benign growth that can become malignant (cancerous) over time. Once detected, a polyp may be removed, preventing it from becoming cancerous. Who is at risk? • People over 50 • People with a personal history of colon or rectal cancer or chronic inflammatory bowel disease • People with a strong family history of colon or rectal cancer or polyps, or any type of cancer • People who are physically inactive • People who eat high-fat, low-fiber diets • Tobacco users What are the symptoms? • A change in bowel habits lasting for more ...

  [284] Dietary Isothiocyanates as Confounding Factors in the Molecular ...
      PDF [339,8 KB]  From [cebp.aacrjournals.org]  Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that connects the small intestine to the rectum. Cancer can begin in any part of the colon , but before cancer develops, changes usually occur in the organ’s lining. One change is a tissue growth called a polyp, which is a benign growth that can become malignant (cancerous) over time. Once detected, a polyp may be removed, preventing it from becoming cancerous. Who is at risk? • People over 50 • People with a personal history of colon or rectal cancer or chronic inflammatory bowel disease • People with a strong family history of colon or rectal cancer or polyps, or any type of cancer • People who are physically inactive • People who eat high-fat, low-fiber diets • Tobacco users What are the symptoms? • A change in bowel habits lasting for more ...

  [285] Constipation, Anthranoid Laxatives, Melanosis Coli, and Colon ...
      PDF [38,3 KB]  From [cebp.aacrjournals.org]  Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that connects the small intestine to the rectum. Cancer can begin in any part of the colon , but before cancer develops, changes usually occur in the organ’s lining. One change is a tissue growth called a polyp, which is a benign growth that can become malignant (cancerous) over time. Once detected, a polyp may be removed, preventing it from becoming cancerous. Who is at risk? • People over 50 • People with a personal history of colon or rectal cancer or chronic inflammatory bowel disease • People with a strong family history of colon or rectal cancer or polyps, or any type of cancer • People who are physically inactive • People who eat high-fat, low-fiber diets • Tobacco users What are the symptoms? • A change in bowel habits lasting for more ...

  [286] Levels of Colorectal Ornithine Decarboxylase Activity in Patients ...
      PDF [693,0 KB]  From [cebp.aacrjournals.org]  Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that connects the small intestine to the rectum. Cancer can begin in any part of the colon , but before cancer develops, changes usually occur in the organ’s lining. One change is a tissue growth called a polyp, which is a benign growth that can become malignant (cancerous) over time. Once detected, a polyp may be removed, preventing it from becoming cancerous. Who is at risk? • People over 50 • People with a personal history of colon or rectal cancer or chronic inflammatory bowel disease • People with a strong family history of colon or rectal cancer or polyps, or any type of cancer • People who are physically inactive • People who eat high-fat, low-fiber diets • Tobacco users What are the symptoms? • A change in bowel habits lasting for more ...

  [287] Microsatellite Instability in Sporadic Colon Cancer Is Associated ...
      PDF [356,6 KB]  From [cebp.aacrjournals.org]  Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that connects the small intestine to the rectum. Cancer can begin in any part of the colon , but before cancer develops, changes usually occur in the organ’s lining. One change is a tissue growth called a polyp, which is a benign growth that can become malignant (cancerous) over time. Once detected, a polyp may be removed, preventing it from becoming cancerous. Who is at risk? • People over 50 • People with a personal history of colon or rectal cancer or chronic inflammatory bowel disease • People with a strong family history of colon or rectal cancer or polyps, or any type of cancer • People who are physically inactive • People who eat high-fat, low-fiber diets • Tobacco users What are the symptoms? • A change in bowel habits lasting for more ...

  [288] Early Adulthood Physical Activity and Colon Cancer Risk among ...
      PDF [675,2 KB]  From [cebp.aacrjournals.org]  Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that connects the small intestine to the rectum. Cancer can begin in any part of the colon , but before cancer develops, changes usually occur in the organ’s lining. One change is a tissue growth called a polyp, which is a benign growth that can become malignant (cancerous) over time. Once detected, a polyp may be removed, preventing it from becoming cancerous. Who is at risk? • People over 50 • People with a personal history of colon or rectal cancer or chronic inflammatory bowel disease • People with a strong family history of colon or rectal cancer or polyps, or any type of cancer • People who are physically inactive • People who eat high-fat, low-fiber diets • Tobacco users What are the symptoms? • A change in bowel habits lasting for more ...

  [289] Attitudes toward Colon Cancer Gene Testing: Survey of Relatives of ...
      PDF [183,0 KB]  From [cebp.aacrjournals.org]  Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that connects the small intestine to the rectum. Cancer can begin in any part of the colon , but before cancer develops, changes usually occur in the organ’s lining. One change is a tissue growth called a polyp, which is a benign growth that can become malignant (cancerous) over time. Once detected, a polyp may be removed, preventing it from becoming cancerous. Who is at risk? • People over 50 • People with a personal history of colon or rectal cancer or chronic inflammatory bowel disease • People with a strong family history of colon or rectal cancer or polyps, or any type of cancer • People who are physically inactive • People who eat high-fat, low-fiber diets • Tobacco users What are the symptoms? • A change in bowel habits lasting for more ...

  [290] Decisional Consideration of Hereditary Colon Cancer Genetic Test ...
      PDF [49,0 KB]  From [cebp.aacrjournals.org]  Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that connects the small intestine to the rectum. Cancer can begin in any part of the colon , but before cancer develops, changes usually occur in the organ’s lining. One change is a tissue growth called a polyp, which is a benign growth that can become malignant (cancerous) over time. Once detected, a polyp may be removed, preventing it from becoming cancerous. Who is at risk? • People over 50 • People with a personal history of colon or rectal cancer or chronic inflammatory bowel disease • People with a strong family history of colon or rectal cancer or polyps, or any type of cancer • People who are physically inactive • People who eat high-fat, low-fiber diets • Tobacco users What are the symptoms? • A change in bowel habits lasting for more ...

  [291] No association between colon cancer and adenocarcinoma of the ...
      PDF [111,4 KB]  From [gut.bmjjournals.com]  Last viewed: 07.09.2006
for colorectal cancer screening by the recognized scientific bodies, and is not paid for by Medicare or private insurers. Any patients who anticipate trying this technique would probably want to assure that the newer 3-D imaging using multi-slice scanning is used, rather than the more readily available but less reliable 2-D equipment. • The risks related to radiation with CT colonography remain uncertain. Fecal DNA Testing: This test involves collection of a stool sample at home that is mailed to a central laboratory. The laboratory checks for abnormal DNA shed from the surface of colon cancers and polyps. • The test detects 52% of colon cancers and 15% of large polyps. If negative it is repeated every 3 to 5 years. This test is better than a stool blood test but much more expensive. Fecal DNA testing is not nearly as effective as ...

  [292] Anti-p53 Autoantibodies in Colon Cancer Patients
      PDF   From [www.annalsnyas.org]  Last viewed: 07.09.2006
1 IN THIS ISSUE: s Medicinal Plant Research, p. 2 s Studies Need Participants, p. 3 s Mothers With Cancer , p. 2 s People on the Move,p.3 s Streaming Video Server, p. 3 s Calendar, p. 4 Thomas Boyer, M.D., Director of New Arizona Liver Institute Arizona Cancer Center Receives $17 Million Grant for Colon Cancer Prevention Research Arizona Cancer Center researchers have received more than $17 million — the largest single grant to the UA College of Medicine in the past five years — from the National Cancer Institute to support colon cancer preven- tion research. The grant will fund the work of a team of researchers from six major universities over the next five years. “This grant will support the efforts of a team of outstanding cancer researchers who have ...

  [293] n their analysis of 2 studies of colon cancer screen- ing ...
      PDF   From [archinte.ama-assn.org]  Last viewed: 07.09.2006
1 IN THIS ISSUE: s Medicinal Plant Research, p. 2 s Studies Need Participants, p. 3 s Mothers With Cancer , p. 2 s People on the Move,p.3 s Streaming Video Server, p. 3 s Calendar, p. 4 Thomas Boyer, M.D., Director of New Arizona Liver Institute Arizona Cancer Center Receives $17 Million Grant for Colon Cancer Prevention Research Arizona Cancer Center researchers have received more than $17 million — the largest single grant to the UA College of Medicine in the past five years — from the National Cancer Institute to support colon cancer preven- tion research. The grant will fund the work of a team of researchers from six major universities over the next five years. “This grant will support the efforts of a team of outstanding cancer researchers who have ...

  [294] Apoptosis in Cultured Human Colon Cancer Cells Induced by Combined ...
      PDF [732,7 KB]  From [jjco.oxfordjournals.org]  Last viewed: 07.09.2006
1 IN THIS ISSUE: s Medicinal Plant Research, p. 2 s Studies Need Participants, p. 3 s Mothers With Cancer , p. 2 s People on the Move,p.3 s Streaming Video Server, p. 3 s Calendar, p. 4 Thomas Boyer, M.D., Director of New Arizona Liver Institute Arizona Cancer Center Receives $17 Million Grant for Colon Cancer Prevention Research Arizona Cancer Center researchers have received more than $17 million — the largest single grant to the UA College of Medicine in the past five years — from the National Cancer Institute to support colon cancer preven- tion research. The grant will fund the work of a team of researchers from six major universities over the next five years. “This grant will support the efforts of a team of outstanding cancer researchers who have ...

  [295] An Orthotopic Mouse Model of Remetastasis of Human Colon Cancer ...
      PDF [306,3 KB]  From [clincancerres.aacrjournals.org]  Last viewed: 07.09.2006
676 N ORTH S T . C LAIR , S UITE 1200 C HICAGO , I LLINOIS 60611-3013 (312) 695-1300 Contact: Amanda Widtfeldt awidtfel@nmh.org 312-926-2955 Northwestern Memorial Hospital Northwestern's cancer genetics program ID's gene variant that increases colon cancer risk CHICAGO – A paper published in this week's Journal of Clinical Oncology says Transforming Growth Factor Beta Receptor 1*6A (TGFBR1*6A) – a mutated gene present in nearly one in eight people and the most commonly inherited cancer susceptibility gene identified so far – might be responsible for a significant proportion of familial colorectal cancers. The study, published by researchers at Northwestern Memorial Hospital and Northwestern University's Robert H. Lurie Comprehensive Cancer Center, says 15 to 20 percent ...

  [296] Expression of Uncoupling Protein-2 in Human Colon Cancer
      PDF [186,7 KB]  From [clincancerres.aacrjournals.org]  Last viewed: 07.09.2006
676 N ORTH S T . C LAIR , S UITE 1200 C HICAGO , I LLINOIS 60611-3013 (312) 695-1300 Contact: Amanda Widtfeldt awidtfel@nmh.org 312-926-2955 Northwestern Memorial Hospital Northwestern's cancer genetics program ID's gene variant that increases colon cancer risk CHICAGO – A paper published in this week's Journal of Clinical Oncology says Transforming Growth Factor Beta Receptor 1*6A (TGFBR1*6A) – a mutated gene present in nearly one in eight people and the most commonly inherited cancer susceptibility gene identified so far – might be responsible for a significant proportion of familial colorectal cancers. The study, published by researchers at Northwestern Memorial Hospital and Northwestern University's Robert H. Lurie Comprehensive Cancer Center, says 15 to 20 percent ...

  [297] Thymidylate Synthase Expression Correlates Closely with E2F1 ...
      PDF [50,6 KB]  From [clincancerres.aacrjournals.org]  Last viewed: 07.09.2006
676 N ORTH S T . C LAIR , S UITE 1200 C HICAGO , I LLINOIS 60611-3013 (312) 695-1300 Contact: Amanda Widtfeldt awidtfel@nmh.org 312-926-2955 Northwestern Memorial Hospital Northwestern's cancer genetics program ID's gene variant that increases colon cancer risk CHICAGO – A paper published in this week's Journal of Clinical Oncology says Transforming Growth Factor Beta Receptor 1*6A (TGFBR1*6A) – a mutated gene present in nearly one in eight people and the most commonly inherited cancer susceptibility gene identified so far – might be responsible for a significant proportion of familial colorectal cancers. The study, published by researchers at Northwestern Memorial Hospital and Northwestern University's Robert H. Lurie Comprehensive Cancer Center, says 15 to 20 percent ...

  [298] Thymidylate Synthase Protein Expression in Advanced Colon Cancer ...
      PDF [24,5 KB]  From [clincancerres.aacrjournals.org]  Last viewed: 07.09.2006
676 N ORTH S T . C LAIR , S UITE 1200 C HICAGO , I LLINOIS 60611-3013 (312) 695-1300 Contact: Amanda Widtfeldt awidtfel@nmh.org 312-926-2955 Northwestern Memorial Hospital Northwestern's cancer genetics program ID's gene variant that increases colon cancer risk CHICAGO – A paper published in this week's Journal of Clinical Oncology says Transforming Growth Factor Beta Receptor 1*6A (TGFBR1*6A) – a mutated gene present in nearly one in eight people and the most commonly inherited cancer susceptibility gene identified so far – might be responsible for a significant proportion of familial colorectal cancers. The study, published by researchers at Northwestern Memorial Hospital and Northwestern University's Robert H. Lurie Comprehensive Cancer Center, says 15 to 20 percent ...

  [299] Nuclear Matrix Protein Alterations Associated with Colon Cancer ...
      PDF [313,4 KB]  From [clincancerres.aacrjournals.org]  Last viewed: 07.09.2006
676 N ORTH S T . C LAIR , S UITE 1200 C HICAGO , I LLINOIS 60611-3013 (312) 695-1300 Contact: Amanda Widtfeldt awidtfel@nmh.org 312-926-2955 Northwestern Memorial Hospital Northwestern's cancer genetics program ID's gene variant that increases colon cancer risk CHICAGO – A paper published in this week's Journal of Clinical Oncology says Transforming Growth Factor Beta Receptor 1*6A (TGFBR1*6A) – a mutated gene present in nearly one in eight people and the most commonly inherited cancer susceptibility gene identified so far – might be responsible for a significant proportion of familial colorectal cancers. The study, published by researchers at Northwestern Memorial Hospital and Northwestern University's Robert H. Lurie Comprehensive Cancer Center, says 15 to 20 percent ...

  [300] Peanut lectin-induced proliferation of HT29 colon cancer cells is ...
      PDF   From [glycob.oxfordjournals.org]  Last viewed: 07.09.2006
What You Need To Know About Cancer of the Colon and Rectum U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute ™ What You Need To Know About Index Page 2 This booklet is about colon and rectal cancer . The Cancer Information Service can help you learn more about this disease. The staff can talk with you in English or Spanish. The number is 1–800–4– CANCER (1–800–422–6237). The number for deaf and hard of hearing callers with TTY equipment is 1–800–332–8615. The call is free. Este folleto es acerca del cáncer de colon y recto. Llame al Servicio de Información sobre el Cáncer para saber más sobre esta enfermedad. Este servicio tiene personal que habla español. ...